TransCode Advances TTX-MC138 in Phase 1a Cancer Trial
Boston, Massachusetts, U.S., September 28, 2026 TransCode Therapeutics has reported updated clinical findings from its ongoing follow-up of the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Boston, Massachusetts, U.S., September 28, 2026 TransCode Therapeutics has reported updated clinical findings from its ongoing follow-up of the...
Sarasota, Florida, U.S., September 28, 2026 Lakewood-Amedex Biotherapeutics has announced positive Minimum Inhibitory Concentration (MIC) data demonstrating in vitro...
Atlantic City, New Jersey, U.S., September 28, 2026 SetPoint Medical has announced an important clinical-access milestone following the completion...
